Table 3.

Treatment and prognosis of patients with HPVG.

Variable	Value (%)
Number of patients eligible for surgery and without contraindications	9 (42.9)
Number of patients undergoing surgical treatment	8 (38.1)
Laparoscopic rectal cancer resection + left lateral sectionectomy of the liver + cholecystectomy	1 (4.8)
Subtotal resection of the entire small intestine and colon	1 (4.8)
Pylorus-preserving gastrectomy + gastrojejunostomy + duodenoplasty + bile duct repair	1 (4.8)
Right hemicolectomy + adhesiolysis	1 (4.8)
Distal ileal resection + partial ascending colon resection + ileostomy	1 (4.8)
Small intestine resection + right hemicolectomy + small bowel stoma	1 (4.8)
Laparotomy + hemostasis of intra-abdominal bleeding, followed by hepatic artery angiography	1 (4.8)
Number of patients eligible for surgery but not operated on	3 (14.3)
End-stage sigmoid colon adenocarcinoma, previous uremia, multi-organ failure	1 (4.8)
End-stage rectal cancer with gastrointestinal perforation and bleeding	1 (4.8)
Postoperative pancreatic malignancy, intestinal perforation and bleeding	1 (4.8)
Survival rate (%) of surgical patients	6 (75.0)
Number of patients receiving conservative treatment	13 (61.9)
Number of surviving patients and survival rate (%) of patients receiving conservative treatment	10 (76.9)
Number of patients cured and discharged	16 (76.2)
Number of patients who died in hospital or were discharged on their own accord	5 (23.8)
Number of patients who died after surgical treatment	2 (9.5)
Abdominal vascular embolization with extensive necrosis of gastrointestinal organs	1 (4.8)
Post-duodenal surgery duodenal fistula, severe infection	1 (4.8)
Number of patients who died after conservative treatment	3 (14.3)
Sigmoid colon adenocarcinoma with gastrointestinal bleeding, history of uremia	1 (4.8)
Rectal cancer with intestinal perforation, bleeding, and necrosis	1 (4.8)
Postoperative pancreatic malignancy, intestinal perforation and bleeding necrosis	1 (4.8)
Cause of death in deceased patients
Malignant intestinal tumor with gastrointestinal bleeding	2 (9.5)
Gastrointestinal bleeding without intestinal necrosis	1 (4.8)
Intestinal necrosis without gastrointestinal bleeding	1 (4.8)
Intestinal bleeding and necrosis	2 (9.5)
With hypertension	4 (19.0)
Number of patients with non-end-stage malignant tumors	15 (71.4)
Number of surviving patients and survival rate of patients with non-end-stage malignant tumors	13 (86.7)
Number of patients with non-end-stage malignant tumors receiving surgical treatment	7 (46.7)
Number of surviving patients and survival rate of patients with non-end-stage malignant tumors receiving surgical treatment	5 (71.4)
Number of patients with non-end-stage malignant tumors receiving conservative treatment	8 (53.3)
Number of surviving patients and survival rate of patients with non-end-stage malignant tumors receiving conservative treatment	8 (100)